Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.03K Hold
1,000
– – ﹤0.01% 2165
2026
Q2
$1.53K Hold
1,000
– – ﹤0.01% 2228
2026
Q1
$1.81K Hold
1,000
– – ﹤0.01% 2161
2025
Q4
$1.35K Hold
1,000
– – ﹤0.01% 2227
2025
Q3
$1.63K Hold
1,000
– – ﹤0.01% 2193
2025
Q2
$970 Buy
1,000
+500
+100% +$415 ﹤0.01% 2255
2025
Q1
$353 Hold
500
– – ﹤0.01% 2391
2024
Q4
$403 Hold
500
– – ﹤0.01% 2341
2024
Q3
$775 Hold
500
– – ﹤0.01% 2737
2024
Q2
$820 Hold
500
– – ﹤0.01% 2564
2024
Q1
$820 Buy
+500
New +$419 ﹤0.01% 1967

Other funds holding OCGN

Blue Trust's OCGN Position: Q3 2026 in Review

Blue Trust held its Ocugen (OCGN) position steady in Q3 2026 at 1,000 shares worth $1.03K. The position accounts for ﹤0.01% of the portfolio, ranked #2165.

Blue Trust first reported a position in OCGN in Q1 2024 and has held it in 11 quarters since. The position peaked at $1.81K in Q1 2026. 111 funds tracked by Wall St. Rank hold OCGN as of Q3 2026.

  • Blue Trust held 1,000 shares of Ocugen worth $1.03K as of Q3 2026.
  • Blue Trust left its Ocugen share count unchanged in Q3 2026.
  • Ocugen made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2165 holding.
  • Blue Trust first reported a position in Ocugen in Q1 2024 and has held it in 11 quarters since.
  • Blue Trust's Ocugen position peaked at $1.81K in Q1 2026.
  • 111 funds tracked by Wall St. Rank held Ocugen as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.